Validation of Roche immunoassay for severe acute respiratory coronavirus 2 in South Africa

Créateur:

JurEliWenJon

Éditeur:

AOS

Hôte:

Visit

Licenses

https://creativecommons.org/licenses/by/4.0

Similaires

Severe Acute Respiratory Syndrome Coronavirus-2 seropositivity in South-Central Uganda, during 2019 - 2021Severe Acute Respiratory Syndrome Coronavirus-2 seroprevalence in South-Central Uganda, during 2019–2021Evaluation of serological lateral flow assays for severe acute respiratory syndrome coronavirus-2Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Healthcare Workers in South Africa: A Longitudinal Cohort StudySevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Africa: Current Considerations and Future ProjectionsInvestigation of Four Clusters of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Rwanda, 2020

Severe Acute Respiratory Syndrome Coronavirus-2 seropositivity in South-Central Uganda, during 2019 - 2021

Abstract Globally, key subpopulations have a high risk of contracting SARS-CoV-2.

Severe Acute Respiratory Syndrome Coronavirus-2 seroprevalence in South-Central Uganda, during 2019–2021

Abstract Background Globally, key su

Evaluation of serological lateral flow assays for severe acute respiratory syndrome coronavirus-2

BACKGROUND Serological testing for SARS-CoV-2 plays an important role for epidemiological studies

Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Healthcare Workers in South Africa: A Longitudinal Cohort Study

Abstract From April to September 2020, we investigated severe acute respiratory syn

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Africa: Current Considerations and Future Projections

Abstract The burden of severe Covid-19 has been relatively low in sib-Saharan Afric

Investigation of Four Clusters of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Rwanda, 2020

We reported the findings of the first Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) f